| LP156469-1 | Hip dysfunction and Osteoarthritis Outcome Score | METHOD | 57 |
| LP15647-8 | Hydroxocobalamin | COMPONENT | 6 |
| LP156470-9 | Knee Injury and Osteoarthritis Outcome Score | METHOD | 59 |
| LP156471-7 | Mini-Mental Status Examination | METHOD | 2 |
| LP156473-3 | Alcohol Use Disorders Identification Test | METHOD | 2 |
| LP156474-1 | Alcohol Use Disorders Identification Test-Consumption | METHOD | 2 |
| LP156476-6 | Clinical Dementia Rating Scale | METHOD | 1 |
| LP156477-4 | Blessed Orientation-Memory-Concentration Test | METHOD | 2 |
| LP156478-2 | Brigance II Screen | METHOD | 1 |
| LP156479-0 | Veterans RAND | METHOD | 98 |
| LP15648-6 | Hydroxylysine | COMPONENT | 16 |
| LP156480-8 | Fall Behavioral Scale | METHOD | 1 |
| LP156482-4 | Michigan Alcoholism Screening Test | METHOD | 1 |
| LP156483-2 | Michigan Alcoholism Screening Test-Geriatric Version | METHOD | 1 |
| LP156484-0 | Car, relax, alone, forget, friends, trouble (CRAFFT) | METHOD | 1 |
| LP156485-7 | Parents' Evaluation of Developmental Status | METHOD | 1 |
| LP156486-5 | Parents' Evaluation of Developmental Status-Developmental Milestones | METHOD | 1 |
| LP156487-3 | Per age, sex and height | METHOD | 3 |
| LP156489-9 | Child Devleopment Inventory | METHOD | 1 |
| LP15649-4 | Hydroxymethylglutaryl CoA lyase | COMPONENT | 1 |
| LP156490-7 | Infant Devleopment Inventory | METHOD | 1 |
| LP156491-5 | Health Assessment Questionnaire | METHOD | 31 |
| LP156492-3 | Kansas City Cardiomyopathy Questionnaire | METHOD | 34 |
| LP156493-1 | Ages and Stages Questionnaires | METHOD | 18 |
| LP156494-9 | Tolerance, worried, eye- opener, amnesia, cutdown screening test | METHOD | 1 |
| LP156495-6 | Census tract | SUPER SYSTEM | |
| LP15650-2 | Hydroxyproline | COMPONENT | 23 |
| LP156500-3 | Resuscitation attempted | COMPONENT | 1 |
| LP156501-1 | Complaint | COMPONENT | 3 |
| LP156502-9 | Reason medication not given | COMPONENT | 1 |
| LP156503-7 | Reason procedure not performed | COMPONENT | 1 |
| LP156504-5 | PM trough specimen | CHALLENGE | |
| LP156505-2 | AM peak specimen | CHALLENGE | |
| LP15651-0 | Hypoxanthine | COMPONENT | 5 |
| LP156511-0 | Sapovirus RNA | COMPONENT | 1 |
| LP15652-8 | Hypoxanthine phosphoribosyltransferase | COMPONENT | 6 |
| LP15653-6 | IgA.monoclonal | COMPONENT | 7 |
| LP156530-0 | Reason medication not | COMPONENT | |
| LP156531-8 | Bayley Infant Neurodevelopmental Screener | METHOD | 1 |
| LP156532-6 | Minnesota Living with Heart Failure Questionnaire | METHOD | 25 |
| LP156533-4 | Total score - Ages and Stages Questionnaires 2 months | COMPONENT | 1 |
| LP156534-2 | Total score - Ages and Stages Questionnaires 4 months | COMPONENT | 1 |
| LP156535-9 | Total score - Ages and Stages Questionnaires 6 months | COMPONENT | 1 |
| LP156536-7 | Total score - Ages and Stages Questionnaires 8 months | COMPONENT | 1 |
| LP156537-5 | Total score - Ages and Stages Questionnaires 9 months | COMPONENT | 1 |
| LP156538-3 | Total score - Ages and Stages Questionnaires 10 months | COMPONENT | 1 |
| LP156539-1 | Total score - Ages and Stages Questionnaires 12 months | COMPONENT | 1 |
| LP15654-4 | IgD | COMPONENT | 8 |
| LP156540-9 | Total score - Ages and Stages Questionnaires 14 months | COMPONENT | 1 |
| LP156541-7 | Total score - Ages and Stages Questionnaires 16 months | COMPONENT | 1 |